BU-NOT-SET

CONTACT US
Sweden’s strong contract services market
  • Drug product
  • Drug substance
Eyes
Insight
Abuse deterrent formulations: Preventing an opioid epidemic
  • Drug product
Eyes
Insight
Early phase know-how clears pathway to late stage success
  • Drug product
Eyes
Insight
Case study: Advancing therapeutics for myeloma
  • Drug product
Eyes
Insight
CPhI 2018 panel discussion: M&A outlook for pharma
  • Industry trends
Eyes
Insight
Contract Pharma: Recipharm and TraceLink Q&A
  • Manufacturing
Eyes
Insight
Serialisation milestone: Recipharm connects to European Hub
  • Manufacturing
Eyes
Insight
Countdown to EU FMD deadline
  • Manufacturing
Eyes
Insight
Stand-alone serialisation services
  • Manufacturing
Product on track
Fact sheet
Insight
  • Manufacturing
  • Sustainability
Sustainable drug delivery systems: Collaborative innovation to shrink pharma’s packaging footprint
eBook
  • Drug product
  • Manufacturing
ReciPredict - How value by design can bring your drug to market faster
eBook
  • Biologics
  • Manufacturing
Enhancing stability for next-generation therapeutics with lyophilisation
Case study
  • Drug product
  • Manufacturing
Accelerating tablet tech-transfer through predictive modelling
Case study
  • Drug product
  • Manufacturing
Tackling assay variability in liquid vials: A data-driven approach to overcoming challenges
Fact sheet
  • Drug product
  • Manufacturing
Scalable solutions for high potent manufacturing
Insight
  • Drug product
  • Manufacturing
The stabilising power of lyophilisation in next-generation therapeutics
Insight
  • Drug product
  • Manufacturing
Unlocking the power of advanced sterile packaging
Fact sheet
  • Biologics
  • Manufacturing
Advancing continuous bioprocessing with Recimagine™